Dextromethorphan Abuse Leading to Assault, Suicide, or Homicide

Journal of Forensic Sciences

Volumn 57, Issue 5, 2012, Pages 1388-1394

  Logan, Barry K ^a,b   Yeakel, Jillian K ^a   Goldfogel, Gary ^c   Frost, Michael P ^d   Sandstrom, Greg ^e   Wickham, Dennis J ^f  

^a The Fredric Rieders Family Renaissance Foundation   (United States)

^b NMS Labs   (United States)

^c Whatcom County Medical Examiner's Office   (United States)

^d Addiction Medicine   (United States)

^e Kitsap County Coroner's Office   (United States)

^f Clark County Medical Examiner's Office   (United States)

Author keywords

Dextromethorphan; Forensic science; Forensic toxicology; Intoxication; Psychosis; Suicide

Indexed keywords

ANTITUSSIVE AGENT; DEXTROMETHORPHAN;

ADDICTION; ADOLESCENT; ADULT; ARTICLE; BLOOD; CASE REPORT; CHEMICALLY INDUCED DISORDER; DELUSION; FEMALE; FORENSIC TOXICOLOGY; HOMICIDE; HUMAN; MALE; PSYCHOSIS; STAB WOUND; SUICIDE;

ADOLESCENT; ADULT; ANTITUSSIVE AGENTS; DELUSIONS; DEXTROMETHORPHAN; FEMALE; FORENSIC TOXICOLOGY; HOMICIDE; HUMANS; MALE; PSYCHOSES, SUBSTANCE-INDUCED; SUBSTANCE-RELATED DISORDERS; SUICIDE; WOUNDS, STAB;

EID: 84865863890     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2012.02133.x     Document Type: Article

References (47)

1. Schwartz R. Adolescent abuse of dextromethorphan. Clin Pediatr 2005;44:565-8.
2. Suski M, Bujak-Gizycka B, Madej J, Kacka K, Dobrogowski J, Woron J, et al. Co-Administration of Dextromethorphan and morphine: reduction of post-operative pain and lack of influence on morphine metabolism. Basic and Clin Pharm Tox 2010;107:680-4.
3. Lauterbach EC. Dextromethorphan as a potential rapid-acting antidepressant. Med Hypotheses 2011;76(5):717-9.
4. Brown C, Fezoui M, Selig WM, Schwartz CE, Ellis JL. Antitussive activity of sigma-1 receptor agonists in the guinea-pig. Brit J Pharm 2004;141:233-40.
5. Takashima T, Murase S, Iwasaki K, Shimada K. Evaluation of dextromethorphan metabolism using hepatocytes from CYP2D6 poor and extensive metabolizers. Drug Metab Pharmacokinet 2005;20(3):177-82.
6. Boyer E. Dextromethorphan abuse. Pediatr Emerg Care 2004;20(12):858-63.
7. Siemens A. Effects of cannabis in combination with ethanol and other drugs. In: Peterson R, editor. Marijuana research findings: 1980. Rockville, MD: National Institute on Drug Abuse, 1980;167-98.
8. Logan B. Combined dextromethorphan and chlorpheniramine intoxication in impaired drivers. J Forensic Sci 2009;54(5):1176-80.
9. Akins BE, Miranda E, Lacy JM, Logan BK. A multi-drug intoxication fatality involving Xyrem (GHB). J Forensic Sci 2009;54(2):495-6.
10. Leighton KM. Paranoid psychosis after abuse of Actifed. BMJ 1982;284:789-90.
11. Sullivan G. Acute psychosis following intravenous abuse of pseudoephedrine: a case report. J Pscyhopharm 1996;10(4):324-5.
12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV, 4th edn. Washington, DC: American Psychiatric Association, 1994.
13. Mortimer O, Lindström B, Laurell H, Bergman U, Rane A. Dextromethorphan: polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man. Br J Clin Pharmacol 1989;27(2):223-7.
14. Streetman DS, Ellis RE, Nafziger AN, Leeder JS, Gaedigk A, Gotschall R, et al. Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping. Clin Pharmacol Ther 1999;66(5):535-41.
15. de Zeeuw RA, Jonkman JHG. Genetic differences in oxidative drug metabolism. In: Uges DRA, De Zeeuw RA, editors. Forensic toxicology: proceedings of the 25th international meeting of the International Association of Forensic Toxicologists; 1988 June 27-30, Groningen, The Netherlands. Groningen, The Netherlands: International Association of Forensic Toxicologists, 1989;53-64.
16. Steinberg GK, Bell TE, Yenari MA. Dose escalation safety and tolerance study of the N-methyl-D-aspartate antagonist dextromethorphan in neurosurgery patients. J Neurosurg 1996;84(5):860-6.
17. Logan BK, Goldfogel F, Hamilton R, Kuhlman J. Five deaths resulting from abuse of dextromethorphan sold over the internet. J Anal Tox 2009;33:99-103.
18. Cochems A, Harding P, Liddicoat L. Dextromethorphan in Wisconsin drivers. J Anal Toxicol 2007;31(4):227-32.
19. Rosen H. Dextromethorphan/quinidine sulfate (Zenvia) for Pseudobulbar Affect. Drugs Today 2008;44(9):661-8.
20. Pope L, Khalil MH, Berg J, Stiles M, Yakatan G, Sellers E. Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers. J Clin Pharmacol 2004;44:1132-42.
21. Schadel M, Wu D, Otton SV, Kalow W, Sellers EM. Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition. J Clin Psychopharm 1995;15(4):263-9.
22. Zhang Y, Britto MR, Valderhaug KL, Wedlund PJ, Smith RA. Dextromethorphan: enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome P4502D6. Clin Pharmacol Ther 1992;51(6):647-55.
23. Adbel-Rahman SM, Gotschall RR, Kauffman RE, Leeder JS, Kearns GL. Investigation of terbinafine as a CYP2D6 inhibitor in vivo. Clin Pharmacol Ther 1999;65(5):465-72.
24. Lotrich FE, Rosen J, Pollock BG. Dextromethorphan-induced delirium and possible methadone interaction. Am J Geriatr Pharmacother 2005;3(1):17-20.
25. Suzuki M. Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management. Curr Opin Anesthesiol 2009;22:618-22.
26. Abraham B, Adithan C. Genetic polymorphism of CYP2D6. Indian J of Pharm 2001;33:147-69.
27. Hall R, Beresford T, Stickney S, Nasdahl C, Coleman J. Psychiatric reactions produced by respiratory drugs. Psychosomatics 1985;26(7):605-16.
28. Banerji S, Anderson I. Abuse of Coricidin HBP cough and cold tablets: episodes recorded by a poison center. Am J Health-Syst Pharm 2001;58:1811-4.
29. Agostini JV, Leo-Summers LS, Inouye SK. Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients. Arch Intern Med 2001;161:2091-7.
30. Dodds A, Revai E. Toxic psychosis due to dextromethorphan. Med J Australia 1967;2:231.
31. Orrell MW, Campbell PG. Dependence on dextromethorphan hydrobromide. BMJ 1986;293:1242-3.
32. Lambert MT. Paranoid psychosis after abuse of proprietary cold remedies. Br J Psychiatry 1987;151:548-50.
33. Craig D. Psychosis with Vicks Formula 44-D abuse. Can Med Assoc J 1992;146(7):1199-200.
34. Mendez MF. Mania self induced with cough syrup. J Clin Psychiatry 1992;53(5):173-4.
35. Walker J, Yatham LN. Benylin (dextromethorphan) abuse and mania. BMJ 1993;306:896.
36. Murray S, Brewerton T. Abuse of over-the-counter dextromethorphan by teenagers. South Med J 1993;86(10):1151-3.
37. Hinsberger A, Sharma V, Mazmanian M. Cognitive deterioration from long term abuse of dextromethorphan: a case report. J Psychiatr Neurosci 1994;19(5):375-7.
38. Wolfe T, Caravati EM. Massive dextromethorphan ingestion and abuse. Am J Emerg Med 1995;13(2):174-6.
39. Polles A, Griffith JL. Dextromethorphan-induced mania. Psychosomatics 1996;37:71-3.
40. Soutullo CA, Cottingham EM, Keck PF. Psychosis associated with pseudoephedrine and dextromethorphan. J Am Acad Child Adolesc Psychiatry 1999;38(12):1471-2.
41. Roberge R, Hirani K, Rowland P, Berkeley R, Krenzelok E. Dextromethorphan- and pseudoephedrine-induced agitated psychosis and ataxia: case report. J Emerg Med 1999;17(2):285-8.
42. Price LH, Lebel J. Dextromethorphan-induced psychosis. Am J Psychiatry 2000;157(2):304.
43. Miller SC. Dextromethorphan psychosis, dependence and physical withdrawal. Addiction Biol 2005;10:325-7.
44. Sharma A, Dewan V, Petty F. Acute psychosis with coricidin cold medicine. Ann Pharmacother 2005;39:1577-8.
45. DiConsiglio J. Legal and lethal. Choices 2008;Feb, 10-12.
46. Jamison SC, Vasudeva S. A 60-year-old woman with agitation and psychosis following ingestion of dextromethorphan and opioid analgesics. J Psychopharm 2009;23(8):989-91.
47. Amaladoss A, O'Brien S. Cough syrup psychosis. CJEM 2011;13(1): 53-6.